Annual Reports and Related Documents::
Issuer & Securities
Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No
Announcement Details
Announcement Title
Annual Reports and Related Documents
Date &Time of Broadcast
26-Sep-2023 07:12:12
Status
New
Report Type
Annual Report
Announcement Reference
SG230926OTHRGPDV
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Please see attached.
This announcement has been prepared by iX Biopharma Ltd. (the "Company") and its contents have been reviewed by the Company's Sponsor, UOB Kay Hian Private Limited (the "Sponsor"), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.
This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Mr. Lance Tan, Senior Vice President, at 8 Anthony Road, #01-01, Singapore 229957, telephone: (65) 6590 6881.
Additional Details
Period Ended
30/06/2023
Attachments
iX Biopharma - Annual Report 2023.pdf
iX Biopharma - Sustainability Report 2023.pdf
Total size =8656K
Related Announcements
Related Announcements